1. Home
  2. IPAR vs HAE Comparison

IPAR vs HAE Comparison

Compare IPAR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inter Parfums Inc.

IPAR

Inter Parfums Inc.

HOLD

Current Price

$100.57

Market Cap

2.9B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$80.91

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPAR
HAE
Founded
1982
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
IPAR
HAE
Price
$100.57
$80.91
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$116.60
$84.13
AVG Volume (30 Days)
193.4K
933.4K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
3.54%
N/A
EPS Growth
2.34
N/A
EPS
1.35
2.05
Revenue
$1,317,700,000.00
$910,373,000.00
Revenue This Year
$3.86
N/A
Revenue Next Year
$7.89
$5.23
P/E Ratio
$72.86
$38.44
Revenue Growth
21.26
N/A
52 Week Low
$77.21
$47.32
52 Week High
$140.90
$87.32

Technical Indicators

Market Signals
Indicator
IPAR
HAE
Relative Strength Index (RSI) 65.44 83.08
Support Level $92.30 $78.87
Resistance Level $104.32 $86.72
Average True Range (ATR) 3.13 2.92
MACD 0.90 1.60
Stochastic Oscillator 96.18 97.01

Price Performance

Historical Comparison
IPAR
HAE

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: